| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |